Nevertheless, PLGA IL‐1α‐MP administration (equivalent to 0.2 μg/mouse) to NFS/N mice bearing malignant fibrosarcoma tumors showed significantly longer survival rates compared to experimental controls although no toxicity end points were analyzed in vivo.48 This evidence concerns the gene IL1A and fibrosarcoma.